Additional file 1: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Figure S1. Forest plots showing the results of subgroup analysis result of SVR12/24 in dialysis-dependent patients and patients not receiving dialysis. (PDF 6 kb

Additional file 2: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Figure S2. Forest plots showing the results of subgroup analysis result of SVR12/24 in studies applied full dose and decreased dose of sofosbuvir. (PDF 6 kb

Additional file 5: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Figure S5. Forest plots showing the results of subgroup analysis result of SVR12/24 in patients originated from Asia, North America and Europe. (PDF 7 kb

Additional file 3: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Figure S3. Forest plots showing the results of subgroup analysis result of SVR12/24 in studies applied 200 mg QD sofosbuvir or 400 mg/48 h sofosbuvir. (PDF 5 kb

Additional file 4: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Figure S4. Forest plots showing the results of subgroup analysis result of SVR12/24 in dialysis-dependent patients applying different doses of sofosbuvir. (PDF 6 kb

YPI-FINAL.xlsx

this data sets contains some demographic variables and three scale items， indicating with corresponding abbreviation.<br

Descriptive statistics of Grit-S and standardized factor loadings of the original two-factor model.

Descriptive statistics of Grit-S and standardized factor loadings of the original two-factor model.</p

Demographic summary of participants by different groups (N = 2,363).

Demographic summary of participants by different groups (N = 2,363).</p

Means, standard deviations, and the intercorrelation matrix among study variables.

Means, standard deviations, and the intercorrelation matrix among study variables.</p

Mean plot of insurance employees’ Grit-S scores on different statuses of insurance premiums.

Mean plot of insurance employees’ Grit-S scores on different statuses of insurance premiums.</p